Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience.
Pituitary
; 25(3): 420-432, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35022929
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Acromegaly
/
Human Growth Hormone
Limits:
Humans
Language:
En
Journal:
Pituitary
Journal subject:
ENDOCRINOLOGIA
Year:
2022
Type:
Article
Affiliation country:
United States